Global Cardiopulmonary Autotransfusion Systems Market Research Report 2022
Cardiopulmonary Autotransfusion System is a sophisticated device with an exceptionally effective design that provides autologous blood during surgical procedures. Autotransfusion is a process wherein a person receives their own blood for a transfusion, instead of banked allogenic (separate-donor) blood.
Due to the COVID-19 pandemic, the global Cardiopulmonary Autotransfusion Systems market size is estimated to be worth US$ 525.6 million in 2021 and is forecast to a readjusted size of US$ 600.5 million by 2028 with a CAGR of 1.9% during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Cardiopulmonary Autotransfusion Systems market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Cardiopulmonary Autotransfusion Systems landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
Autotransfusion involves the collection of blood before surgeries and its transfusion during cardiac. The increasing prevalence of cardiac diseases has led to rise in cardiac surgeries which has propelled the cardiopulmonary autotransfusion market globally. According to the American Heart Association, globally over 80 million people suffer from heart health problems. This is occurring due to change in life style of people and consumption of high amount of fats and sugar. The complication in allogenic blood transfusion which results in significant loss of blood during cardiac surgery has led to the rise in demand for cardiopulmonary autotransfusion systems. Beside that innovation in the autotransfusion system due to advancement in technology has also boosted the global market of cardiopulmonary autotransfusion devices. Lack of availability of skilled professional for operating cardiopulmonary autotransfusion devices can restrain the growth of this market.
This report focuses on Cardiopulmonary Autotransfusion Systems volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Cardiopulmonary Autotransfusion Systems market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China, Japan, Southeast Asia, India and Central & South America, etc.
Global Cardiopulmonary Autotransfusion Systems Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Unwashed ATS
Washed ATS
Segment by Application
Heart Surgery
Great Organ Transplant Surgery
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
Advancis Surgical
Fresenius Kabi
Haemonetics
LivaNova
Medtronic
Terumo
Atrium Medical
Global Blood Resources
Redax
Sarstedt
Stryker
Due to the COVID-19 pandemic, the global Cardiopulmonary Autotransfusion Systems market size is estimated to be worth US$ 525.6 million in 2021 and is forecast to a readjusted size of US$ 600.5 million by 2028 with a CAGR of 1.9% during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Cardiopulmonary Autotransfusion Systems market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Cardiopulmonary Autotransfusion Systems landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
Autotransfusion involves the collection of blood before surgeries and its transfusion during cardiac. The increasing prevalence of cardiac diseases has led to rise in cardiac surgeries which has propelled the cardiopulmonary autotransfusion market globally. According to the American Heart Association, globally over 80 million people suffer from heart health problems. This is occurring due to change in life style of people and consumption of high amount of fats and sugar. The complication in allogenic blood transfusion which results in significant loss of blood during cardiac surgery has led to the rise in demand for cardiopulmonary autotransfusion systems. Beside that innovation in the autotransfusion system due to advancement in technology has also boosted the global market of cardiopulmonary autotransfusion devices. Lack of availability of skilled professional for operating cardiopulmonary autotransfusion devices can restrain the growth of this market.
This report focuses on Cardiopulmonary Autotransfusion Systems volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Cardiopulmonary Autotransfusion Systems market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China, Japan, Southeast Asia, India and Central & South America, etc.
Global Cardiopulmonary Autotransfusion Systems Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Unwashed ATS
Washed ATS
Segment by Application
Heart Surgery
Great Organ Transplant Surgery
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
Advancis Surgical
Fresenius Kabi
Haemonetics
LivaNova
Medtronic
Terumo
Atrium Medical
Global Blood Resources
Redax
Sarstedt
Stryker
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Please Select a Format
